Education
About Us
Working with TipRanks
Follow Us
CVS Health Corp (IT:1CVS)
:1CVS
Earnings Data
Report Date
Jul 30, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
1.29Last Year’s EPS
1.62Same Quarter Last Year
Strong Buy
Based on 17 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 01, 2025
|% Change Since: 6.72%
|Next Earnings Date:Jul 30, 2025
Earnings Call Sentiment|Neutral
CVS Health delivered strong financial results in Q1 2025 and increased its full-year EPS guidance, reflecting solid performance across all segments. The company is leading in market innovation with expanded access to GLP-1 medications and growth in pharmacy market share. However, challenges persist in individual exchange products, legislative impacts in Arkansas, and elevated medical cost trends. The overall sentiment is cautiously optimistic with strong highlights, but significant lowlights remain.Company Guidance
During the CVS Health Q1 2025 earnings call, the company reported a strong financial performance, with first quarter adjusted earnings per share (EPS) of $2.25 and adjusted operating income of $4.6 billion. CVS Health increased its full-year 2025 adjusted EPS guidance to a range of $6 to $6.20, up from the previous range of $5.75 to $6. The company generated nearly $95 billion in revenue, a 7% increase year-over-year, driven by growth across all segments. The healthcare benefits segment generated nearly $35 billion in revenue, an 8% increase, while the health services segment saw revenues of over $43 billion, reflecting an 8% growth. The pharmacy and consumer wellness segment recorded nearly $32 billion in revenues, an 11% increase compared to the prior year. CVS also processed and dispensed over 1.7 billion prescriptions annually, with a 7% increase in same-store prescription volumes. However, the company is exiting the individual exchange business in 2026, projecting variable losses of $350 million to $400 million for 2025. CVS Health remains committed to innovation and improving healthcare access and affordability through strategic partnerships and digital solutions.Strong Financial Performance in Q1 2025
CVS Health reported first quarter adjusted earnings per share of $2.25 and adjusted operating income of $4.6 billion. Revenue for the quarter was nearly $95 billion, marking a 7% increase over the prior year.
Increased Full Year 2025 EPS Guidance
The company raised its full year 2025 adjusted EPS guidance to a range of $6 to $6.20, up from the previous range of $5.75 to $6, reflecting solid performance and execution across all business segments.
Expansion in GLP-1 Access
CVS announced a partnership with Novo Nordisk to increase access to Wegovy for members at a more affordable price, demonstrating the value of its integrated model and continuing leadership in market innovation.
Pharmacy Market Share Growth
Retail pharmacy script share in Q1 grew to approximately 27.6%, an increase of approximately 70 basis points from the same period last year, driven by strong execution and superior customer experiences.
Successful Leadership Transition
The appointments of Brian Newman as Chief Financial Officer and Amy Compton-Phillips as Chief Medical Officer are expected to support continued momentum and strategic execution.
IT:1CVS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
IT:1CVS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 12, 2025 | €52.17 | €59.87 | +14.77% |
Nov 06, 2024 | €49.20 | €55.88 | +13.58% |
Aug 07, 2024 | €50.95 | €51.53 | +1.16% |
Feb 07, 2024 | €64.70 | €66.76 | +3.19% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does CVS Health Corp (IT:1CVS) report earnings?
CVS Health Corp (IT:1CVS) is schdueled to report earning on Jul 30, 2025, TBA Not Confirmed.
What is CVS Health Corp (IT:1CVS) earnings time?
CVS Health Corp (IT:1CVS) earnings time is at Jul 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of CVS Health Corp stock?
The P/E ratio of CVS Health is N/A.
What is IT:1CVS EPS forecast?
IT:1CVS EPS forecast for the fiscal quarter 2025 (Q2) is 1.29.
